Recalls & Warnings October 20, 2025 FDA Warns Vidaslim for Manufacturing Violations On July 17, 2025, the Food and Drug Administration issued a Warning Letter to Vidaslim Co
People living with obesity can count on Novo Nordisk to partner, educate, and advocate to change how this disease is understood, diagnosed, and treated." Earlier this month, the FDA took two other medications used for weight loss, Mounjaro and Zepbound, off its shortage list
Ongoing support from healthcare professionals Stay on track with expert advice and proven strategies through our online program
Temperature thresholds differ between formulations
Dihexa is a research peptide studied for its ability to activate growth-factor receptors in the brain, and clinicians explore it as one part of a supervised cognitive-health plan rather than a standalone fix